Abstract
A method of acutely reducing the plasma level of PTH of a patient having an elevated PTH comprising the administration of a pharmaceutical composition comprising a GLP-2, or a variant, an analogue, or derivative of GLP-2 having the ability to bind and activate a GLP-2 receptor such as GLP-2 1-34
Originalsprog | Engelsk |
---|---|
Patentnummer | US2010/0081,622 |
Journaliseringsdato | 28/09/2009 |
Land/Område | USA |
Status | Udgivet - 1 apr. 2011 |
Emneord
- Det Sundhedsvidenskabelige Fakultet